Ashtons is a registered pharmacy with the General Pharmaceutical Council, is also registered as an online pharmacy and holds both the Wholesale Dealer’s Licence from the MHRA and the Home Office Controlled Drugs Licence, which both permit the Company to legally supply stock medication. These licences can be accessed below.
General Pharmaceutical Council Registration (GPhC registration number 1087763)
General Pharmaceutical Council (GPhC) is the independent regulator for pharmacists, pharmacy technicians and pharmacy premises in Great Britain. All pharmacies in Great Britain must be registered with GPhC and meet the required standards.
Ashtons’ premises are registered with the General Pharmaceutical Council (GPhC) under the Medicines Act (1968) to supply all medicines and related products, including Prescription Only Medicines (POM).
The dispensary’s policies and procedures also comply with The Misuse of Drugs Act (1971), the Human Medicines Regulations (2012) and The Health Act (2006).
MHRA Wholesaler Dealer’s Licence (number WL 28408/3)
Medicines & Healthcare Regulatory Agency regulates the supply of medicines and medical devices in the UK. It is a legal requirement that any pharmacy provider must have a Wholesale Dealer’s Licence from the MHRA to be able to supply medicines as ‘stock’ to your hospital, without the need to label for each individual patient.
Ashtons holds an MHRA Wholesale Dealer’s Licence. To do so, Ashtons must comply with The Human Medicines Regulations (2012) and also the guidelines on Good Distribution Practice published by the MHRA. All areas are temperature mapped to ensure compliance. All of the medicines and medical devices that we supply must meet acceptable standards on safety, quality and efficacy. Our WDA Licence and GDP licence can be accessed in through the links below:
Home Office Controlled Drugs Licence
Home Office regulates certain medicines in the UK, such as opiates, via The Misuse of Drugs Act and requires the supplier to have a Controlled Drugs Licence. Ashtons holds this licence, and in addition Ashtons plays a significant role in supporting its clients to comply with the increased regulatory governance associated with these medicines. Our CD licence can be accessed through the link below: